JINGHAO MEDICAL
872925
TONGYI AEROSPACE
871642
ESKONJAC
839273
4
Jiangsu Olive Sensors High-Tech
300507
5
Jing-Jin Electric Technologies
688280
CN Stock MarketDetailed Quotes
601985 China National Nuclear Power
- 9.33
- +0.04+0.43%
Not Open May 7 15:00 CST
191.90BMarket Cap21.65P/E (TTM)
9.38High9.27Low712.27KlotVolume9.36Open9.29Pre Close663.24MTurnover0.38%Turnover Ratio21.85P/E (Static)20.57BShares12.2752wk High1.70P/B176.18BFloat Cap8.6652wk Low10.22Limit Up18.88BShs Float13.16Historical High8.36Limit Down1.18%Amplitude2.85Historical Low0.20Dividend TTM9.31Avg Price314.60KlotAsk2.09%Div YieldTTM100Lot Size347.91KlotBid
China National Nuclear Power Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 12.70%20.27B | 3.09%77.27B | 1.60%56.99B | 3.15%37.44B | 0.53%17.99B | 5.15%74.96B | 6.43%56.09B | 4.99%36.3B | 4.64%17.89B | 13.70%71.29B |
| Operating revenue | 12.70%20.27B | 3.09%77.27B | 1.60%56.99B | 3.15%37.44B | 0.53%17.99B | 5.15%74.96B | 6.43%56.09B | 4.99%36.3B | 4.64%17.89B | 13.70%71.29B |
| Other operating revenue | ---- | -31.09%315.96M | ---- | 36.12%158.61M | ---- | 61.64%458.53M | ---- | 26.77%116.53M | ---- | 7.07%283.68M |
| Total operating cost | 13.44%13.47B | 4.22%57.5B | 2.46%39.48B | 2.60%25.64B | -0.93%11.87B | 2.42%55.17B | 4.30%38.53B | 5.32%24.99B | 8.91%11.98B | 14.60%53.87B |
| Operating cost | 15.60%10.57B | 6.28%44.12B | 3.50%30.05B | 5.22%19.65B | 1.90%9.14B | 7.10%41.51B | 10.36%29.04B | 9.38%18.68B | 8.10%8.97B | 11.19%38.76B |
| Operating tax surcharges | 40.13%319.75M | 4.37%1.08B | 6.46%802.54M | -2.47%506.5M | -6.84%228.18M | 18.28%1.03B | 15.39%753.87M | 24.86%519.31M | 35.56%244.93M | 32.08%872.2M |
| Operating expense | 50.27%13.44M | -45.71%62.49M | -32.99%45.4M | -19.56%33.08M | -65.60%8.94M | 48.10%115.11M | 23.99%67.75M | 34.66%41.12M | 56.80%25.99M | -0.99%77.72M |
| Administration expense | 6.34%796.99M | 5.19%4.03B | 13.27%2.53B | 12.62%1.54B | 18.31%749.44M | -17.11%3.83B | -25.85%2.24B | -21.08%1.36B | 24.60%633.45M | 44.17%4.62B |
| Financial expense | 1.45%1.71B | -6.27%6.84B | -2.06%5.29B | -10.80%3.47B | -10.07%1.69B | -10.35%7.3B | -9.25%5.4B | 0.50%3.89B | 7.03%1.87B | 18.54%8.14B |
| -Interest expense (Financial expense) | -5.03%1.63B | -3.23%6.71B | -1.81%5.14B | -3.78%3.45B | -6.02%1.71B | -9.26%6.93B | -7.55%5.24B | -5.30%3.59B | -1.19%1.82B | -0.20%7.64B |
| -Interest Income (Financial expense) | -63.87%-39.99M | 14.90%-155.55M | 18.14%-116.67M | 28.25%-63.71M | 39.44%-24.4M | 12.06%-182.78M | -2.50%-142.52M | -10.17%-88.8M | -9.56%-40.3M | 14.11%-207.84M |
| Research and development | 3.57%58.92M | -0.67%1.37B | -27.03%756.18M | -11.80%438.82M | -75.50%56.89M | -1.01%1.38B | 8.37%1.04B | -17.86%497.5M | -5.88%232.19M | 4.55%1.4B |
| Credit Impairment Loss | -107.72%-3.32M | 21.30%-65.9M | 59.78%-36.6M | 26.12%-64.83M | 95.43%-1.6M | -195.95%-83.73M | -44.80%-91M | -35.50%-87.75M | -98.98%-34.94M | 93.00%87.27M |
| Asset Impairment Loss | --26.62K | -139.45%-498.57M | 563.10%582.47K | 563.10%582.47K | ---- | 15.89%-208.22M | 97.78%-125.78K | 97.55%-125.78K | ---- | 22.90%-247.54M |
| Other net revenue | 34.30%867.93M | -8.70%2.61B | 7.31%2.26B | -2.77%1.42B | -10.61%646.27M | 28.35%2.86B | 26.53%2.11B | 51.17%1.46B | 82.33%723M | 109.58%2.23B |
| Fair value change income | ---- | ---- | ---- | ---- | ---- | 223.08%155.87K | --393.39K | --534.41K | ---70.51K | --48.25K |
| Invest income | -14.52%56.2M | 7.50%410.73M | 44.70%174.43M | 93.27%127.3M | 68.11%65.75M | 38.82%382.07M | -27.76%120.55M | -16.19%65.87M | 56.61%39.11M | 41.34%275.24M |
| -Including: Investment income associates | -13.35%56M | -9.97%338.83M | 45.13%168.21M | 72.62%109.75M | 70.69%64.62M | 39.89%376.37M | -30.64%115.91M | -16.59%63.57M | 58.36%37.86M | 41.85%269.05M |
| Asset deal income | 29,145.14%8.13M | -80.61%11.23M | -99.93%27.79K | -95.88%27.79K | --27.79K | 5,458.38%57.93M | 128,547.23%38.96M | 165.73%674.43K | ---- | -98.24%1.04M |
| Other revenue | 38.62%806.89M | 1.55%2.75B | 4.15%2.12B | -8.41%1.35B | -19.03%582.09M | 28.39%2.71B | 30.08%2.04B | 54.56%1.48B | 84.59%718.91M | 94.62%2.11B |
| Operating profit | 13.46%7.67B | -1.17%22.38B | 0.53%19.77B | 3.56%13.22B | 1.96%6.76B | 15.27%22.65B | 12.84%19.67B | 8.09%12.77B | 2.17%6.63B | 17.27%19.65B |
| Add:Non operating Income | -81.68%11.81M | -43.37%260M | -68.85%114.63M | -69.59%100.46M | 1,685.70%64.45M | 951.62%459.1M | 1,588.02%368.01M | 1,719.14%330.39M | 325.73%3.61M | -80.72%43.66M |
| Less:Non operating expense | 749.29%23.91M | -36.92%78.11M | -3.72%45.96M | -49.73%8.84M | -3.95%2.82M | 4.00%123.82M | -30.68%47.74M | 30.34%17.59M | 11.83%2.93M | -16.41%119.06M |
| Total profit | 12.25%7.66B | -1.82%22.56B | -0.74%19.84B | 1.78%13.31B | 2.88%6.82B | 17.43%22.98B | 14.99%19.99B | 10.70%13.08B | 2.20%6.63B | 16.23%19.57B |
| Less:Income tax cost | 26.42%1.49B | 68.34%6.01B | 8.93%3.53B | 9.92%2.47B | -4.10%1.18B | 9.97%3.57B | 12.83%3.24B | 13.74%2.25B | 8.94%1.23B | 29.63%3.25B |
| Net profit | 9.30%6.17B | -14.72%16.55B | -2.61%16.31B | 0.09%10.84B | 4.46%5.65B | 18.92%19.41B | 15.42%16.75B | 10.09%10.83B | 0.79%5.4B | 13.89%16.32B |
| Net profit from continuing operation | 9.30%6.17B | -14.72%16.55B | -2.61%16.31B | 0.09%10.84B | 4.46%5.65B | 18.92%19.41B | 15.42%16.75B | 10.09%10.83B | 0.79%5.4B | 13.89%16.32B |
| Less:Minority Profit | 17.27%3.03B | -11.51%7.78B | -0.58%7.38B | 3.56%4.96B | 8.63%2.59B | 20.16%8.79B | 14.57%7.42B | 8.85%4.79B | -3.87%2.38B | 19.58%7.31B |
| Net profit of parent company owners | 2.55%3.14B | -17.38%8.78B | -4.22%8.93B | -2.65%5.88B | 1.18%3.06B | 17.91%10.62B | 16.10%9.33B | 11.09%6.04B | 4.79%3.02B | 9.66%9.01B |
| Earning per share | ||||||||||
| Basic earning per share | -6.17%0.152 | -16.43%0.463 | -2.88%0.472 | -0.96%0.311 | 3.18%0.162 | 18.38%0.554 | 15.17%0.486 | 8.65%0.314 | -1.88%0.157 | 4.00%0.468 |
| Diluted earning per share | -6.17%0.152 | -16.43%0.463 | -2.88%0.472 | -0.96%0.311 | 3.18%0.162 | 18.63%0.554 | 15.44%0.486 | 9.03%0.314 | -1.26%0.157 | 7.60%0.467 |
| Other composite income | 3,646.12%8.97M | -548.00%-64.5M | -18,318.38%-31.63M | -896.36%-5.2M | 203.17%239.4K | -9.73%-9.95M | 104.88%173.63K | 119.16%652.63K | 101.26%78.96K | 72.34%-9.07M |
| Other composite income of parent company owners | 3,966.45%5.55M | -474.72%-43.62M | -8,823.46%-21.72M | -606.76%-3.5M | 42.23%136.58K | -4.80%-7.59M | 110.00%249.03K | 129.67%690.15K | 102.37%96.03K | 70.18%-7.24M |
| Other composite income of minority owners | 3,220.57%3.41M | -783.20%-20.88M | -13,042.54%-9.91M | -4,430.83%-1.7M | 702.48%102.81K | -29.27%-2.36M | 92.96%-75.4K | 96.52%-37.52K | 99.22%-17.06K | 78.51%-1.83M |
| Total composite income | 9.45%6.18B | -15.01%16.49B | -2.80%16.28B | 0.04%10.83B | 4.47%5.65B | 18.92%19.4B | 15.45%16.75B | 10.13%10.83B | 0.91%5.4B | 14.09%16.31B |
| Total composite income of parent company owners | 2.73%3.14B | -17.73%8.73B | -4.46%8.91B | -2.72%5.88B | 1.18%3.06B | 17.92%10.62B | 16.14%9.33B | 11.15%6.04B | 4.94%3.02B | 9.90%9B |
| Total composite income of minority owners | 17.40%3.04B | -11.72%7.75B | -0.71%7.37B | 3.52%4.96B | 8.63%2.59B | 20.16%8.78B | 14.58%7.42B | 8.88%4.79B | -3.79%2.38B | 19.71%7.31B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.